Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00142571 | Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma | completed | Phase 3 | 120 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 2, 2007 | clinicaltrials |
| NCT00001561 | Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation | completed | Phase 3 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 24, 2007 |
| clinicaltrials |
| NCT00529412 | Bioresorbable Membrane to Reduce Postoperative Small Bowel Obstruction | completed | Phase 3 | 150 | Nihon UniversityOTHER | 1 | Sep 14, 2007 | clinicaltrials |
| NCT00294359 | The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 / Phase 3 | 333 | Australasian Gastro-Intestinal Trials GroupNETWORK | 2 | Aug 22, 2007 | clinicaltrials |
| NCT00036556 | Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 941 | AbbottINDUSTRY | 17 | Aug 15, 2007 | clinicaltrials |
| NCT00514488 | Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)(CML022) | completed | Phase 3 | — | University of BolognaOTHER | 1 | Aug 10, 2007 | clinicaltrials |
| NCT00145652 | Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. | completed | Phase 3 | 66 | Sundsvall HospitalOTHER | 1 | Jul 30, 2007 | clinicaltrials |
| NCT00169130 | ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma | completed | Phase 2 / Phase 3 | 300 | Lymphoma Study AssociationOTHER | 2 | Jul 13, 2007 | clinicaltrials |
| NCT00136552 | Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden | completed | Phase 3 | 360 | Lymphoma Study AssociationOTHER | 2 | Jul 3, 2007 | clinicaltrials |
| NCT00201929 | A Decision Aid for Women With Early Stage Breast Cancer | completed | Phase 3 | 300 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00494546 | High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer | completed | Phase 3 | 568 | VA Puget Sound Health Care SystemFED | 1 | Jun 29, 2007 | clinicaltrials |
| NCT00344526 | Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis | completed | Phase 3 | 100 | University Hospital, LimogesOTHER | 1 | Jun 28, 2007 | clinicaltrials |
| NCT00207324 | The Use of Silver Leaf Dressing in the Prevention of Radiotherapy Induced Skin Reactions | completed | Phase 3 | 100 | British Columbia Cancer AgencyOTHER | 1 | Jun 27, 2007 | clinicaltrials |
| NCT00483132 | Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III | completed | Phase 3 | 232 | French Innovative Leukemia OrganisationOTHER | 1 | Jun 6, 2007 | clinicaltrials |
| NCT00480064 | Lomustine and Intermediate Dose Cytarabine in Older Patients With AML | completed | Phase 3 | 360 | French Innovative Leukemia OrganisationOTHER | 1 | May 30, 2007 | clinicaltrials |
| NCT00191438 | Phase III Study of Gemcitabine Plus a Cytotoxic Agent Versus Two Cytotoxic Agents | completed | Phase 3 | 300 | Eli Lilly and CompanyINDUSTRY | 6 | May 28, 2007 | clinicaltrials |
| NCT00114816 | Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer | completed | Phase 3 | 1,500 | Finnish Breast Cancer GroupOTHER | 1 | May 21, 2007 | clinicaltrials |
| NCT00054795 | Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | completed | Phase 3 | 550 | Pharmacyclics LLC.INDUSTRY | 8 | May 8, 2007 | clinicaltrials |
| NCT00039910 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 240 | PfizerINDUSTRY | 8 | May 4, 2007 | clinicaltrials |
| NCT00467948 | Comparison of 2 Cefazolin Prophylactic Protocol in Laryngectomy Patients | completed | Phase 3 | 90 | Tehran University of Medical SciencesOTHER | 1 | May 1, 2007 | clinicaltrials |
| NCT00135876 | Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients | completed | Phase 3 | 512 | Ontario Clinical Oncology Group (OCOG)OTHER | 4 | Apr 27, 2007 | clinicaltrials |
| NCT00144378 | Irinotecan Versus Only Best Supportive Care for Gastric Cancer | completed | Phase 3 | 44 | Charite University, Berlin, GermanyOTHER | 1 | Apr 18, 2007 | clinicaltrials |
| NCT00147862 | Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery? | completed | Phase 3 | 240 | Tata Memorial HospitalOTHER_GOV | 1 | Feb 7, 2007 | clinicaltrials |
| NCT00430911 | Radiotherapy for Malignant Astrocytomas in the Elderly | completed | Phase 3 | — | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 2, 2007 | clinicaltrials |
| NCT00190593 | Raloxifene Use for The Heart | completed | Phase 3 | 10,000 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00190762 | A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma | completed | Phase 3 | 240 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00191607 | A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. | completed | Phase 3 | 162 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 26, 2007 | clinicaltrials |
| NCT00376883 | Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month | completed | Phase 3 | 500 | Nordic Myeloma Study GroupOTHER | 3 | Jan 4, 2007 | clinicaltrials |
| NCT00102414 | Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer | completed | Phase 3 | 356 | AGO Study GroupOTHER | 0 | Nov 14, 2006 | clinicaltrials |
| NCT00037791 | Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia | completed | Phase 3 | 180 | PfizerINDUSTRY | 3 | Nov 9, 2006 | clinicaltrials |
| NCT00161980 | Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | completed | Phase 3 | — | Baxter Healthcare CorporationINDUSTRY | 4 | Oct 23, 2006 | clinicaltrials |
| NCT00300664 | A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. | completed | Phase 2 / Phase 3 | 150 | Royal Marsden NHS Foundation TrustOTHER | 0 | Oct 13, 2006 | clinicaltrials |
| NCT00359060 | Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study | completed | Phase 3 | 180 | UMC UtrechtOTHER | 1 | Oct 13, 2006 | clinicaltrials |
| NCT00386984 | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma | completed | Phase 3 | 108 | University Hospital FreiburgOTHER | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00378222 | Autologous Transplantation for Multiple Myeloma | completed | Phase 3 | 324 | University of BolognaOTHER | 0 | Sep 19, 2006 | clinicaltrials |
| NCT00272051 | XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV Chemotherapy | completed | Phase 3 | 620 | SanofiINDUSTRY | 0 | Sep 13, 2006 | clinicaltrials |
| NCT00136669 | Acupuncture For Pancreatic Cancer Pain | completed | Phase 3 | 60 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00138112 | Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation | completed | Phase 3 | 126 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 8, 2006 | clinicaltrials |
| NCT00367185 | Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma | completed | Phase 3 | 500 | University Hospital, LilleOTHER | 1 | Aug 22, 2006 | clinicaltrials |
| NCT00036543 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | completed | Phase 3 | 1,000 | AbbottINDUSTRY | 18 | Aug 15, 2006 | clinicaltrials |
| NCT00102375 | Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer | completed | Phase 3 | 900 | AGO Study GroupOTHER | 1 | Aug 4, 2006 | clinicaltrials |
| NCT00034125 | Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 5 | Jul 19, 2006 | clinicaltrials |
| NCT00034268 | A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 21 | Jul 19, 2006 | clinicaltrials |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 18 | Jul 19, 2006 | clinicaltrials |
| NCT00352404 | Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia | completed | Phase 3 | 114 | Johannes Gutenberg University MainzOTHER | 1 | Jul 14, 2006 | clinicaltrials |
| NCT00046527 | Study of ABI-007 and Taxol in Patients With Metastatic Breast Cancer | completed | Phase 3 | 460 | Celgene CorporationINDUSTRY | 1 | Jul 13, 2006 | clinicaltrials |
| NCT00144079 | Multicenter Study Differentiated Thyroid Carcinoma | completed | Phase 3 | 500 | University Hospital MuensterOTHER | 3 | May 9, 2006 | clinicaltrials |
| NCT00237562 | Feasibility of the Management of Severe Cervical Dysplasia in a Single Visit | completed | Phase 3 | — | University of California, IrvineOTHER | 1 | May 5, 2006 | clinicaltrials |
| NCT00312988 | Topotecan Vs. Topotecan + Etoposide Vs.Topotecan + Gemcitabine in Ovarian Cancer Therapy | completed | Phase 3 | 450 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Apr 11, 2006 | clinicaltrials |
| NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | completed | Phase 3 | 598 | Austrian Breast & Colorectal Cancer Study GroupNETWORK | 1 | Apr 3, 2006 | clinicaltrials |
Data updated 22 days agoSource updated Oct 2, 2007source: clinicaltrials